Presentation Information
[F2-34]Establishment of guidelines for designing useful vaccine antigens and production of new COVID-19 vaccine antigen
*Takuya Hemmi1, Takao Hashiguchi1 (1. Institute for Life and Medical Sciences, Kyoto University (Japan))
Login required to view
Comment
To browse or post comments, you must log in.Log in
